Arkolith/Funds/Lisanti Capital Growth, LLC

Lisanti Capital Growth, LLC

CIK 1424467
Holdings as of Jun 30, 2026·disclosed Aug 10, 2026·~41-day 13F lag·13F-HR
Active Filer

Lisanti Capital Growth, LLC holds a diversified book of 109 stocks worth $454.6M as of Q2 2026 (disclosed Aug 10, 2026, a ~41-day 13F lag). This quarter Madison Air Solutions Corp-A first appears in 13F filings (one of 2 new listings in the book), a listing rather than a purchase; they opened Xometry Inc-A and trimmed Brightspring Health Services. Their largest long position is Hinge Health Inc-A at 3% of the equity book. Cloning the disclosed picks since 2024 would be +34% (+17.2%/yr). That is a simulation of the disclosed long book, not audited returns.

Opened
48
bought for the first time
+45 more · largest first
2 newly reportable · first quarter we see the security in 13F filings, a listing not a purchase
Sold out
44
exited the position entirely
+41 more · largest first, by prior value

Growth of $10,000: cloning the disclosed book

If you'd copied them
+33.8%
+17.2%/yr · since Nov '24
Their reported book
+16.3%
held from quarter-end
S&P 500
+36.8%
same window
$7K$9K$11K$13K$15KNov '24Mar '25Jul '25Dec '25Apr '26Sep '26
Lisanti Capital Growth, LLC (copied at disclosure) S&P 500

Following at the filing date actually beat the quarter-end book by 17.6 points over this window.

Growth of $10,000 cloning Lisanti Capital Growth, LLC's disclosed long 13F book, rebalanced on each filing date (so it reflects each quarter's actual reporting lag, ~41 days for the latest filing, with no look-ahead), total-return basis (dividends reinvested), derived from end-of-day prices. “Their reported book” values the same picks from quarter-end, before they were public. S&P 500 is SPY total return over the same window. Excludes shorts, cash, options and non-13F holdings. Not investment advice.

How much sits in the biggest positions

Top-heavy: diversified book

Top 5 holdings
11%
Top 10 holdings
19%
Top 20 holdings
34%

Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.

Where the money is, by sector

100% mapped to company sectors

Information Technology
35%
Industrials
26%
Health Care
22%
Consumer Discretionary
6%
Materials
4%
Financials
3%
Communication Services
2%
Consumer Staples
2%

+2 sectors below the cut, under 0.5% together

Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.

Biggest moves: latest quarter

Estimated $ traded · quarter-end prices (an exit at the prior quarter-end), no cost basis

Bought
Trimmed / exited
Newly reportable· first quarter we see the security in 13F filings · position value, not a trade

Funds with the most overlap

Other tracked managers holding the same core names as Lisanti Capital Growth, LLC

Manager / fundShared namesTheir $ in those
G2 Investment Partners Management LLC15 / 80$134.1M
Emerald Advisers, LLC31 / 80$1.3B
Emerald Mutual Fund Advisers Trust32 / 80$860.9M
Next Century Growth Investors LLC22 / 80$558.0M
Hood River Capital Management LLC20 / 80$3.9B
Renaissance Capital LLC8 / 80$46.8M
Pier Capital, LLC21 / 80$188.7M
Legato Capital Management LLC77 / 80$300.5M

Ranked by the share of each fund's own book sitting in the names it shares with Lisanti Capital Growth, LLC: only funds sharing at least a tenth of the book qualify. Index giants, bank custody books and market makers are excluded. They hold everything, so their overlap says nothing.

Holdings: largest first

Bars show each stock's share of the portfolio. Click a row for its position history.

109 positions
#SecurityValueShares% PortLast moveHistory
1Hinge Health Inc
CL A
$11.5M139.2K
2.5%
+135%
Added · +80K sh
2Brightspring Health Svcs Inc
COM
$10.8M154.6K
2.4%
−18%
Reduced · −35K sh
3Xometry Inc
CLASS A COM
$9.7M100.9K
2.1%
New
New position
4Solaris Energy Infras Inc
COM CL A
$9.2M114.7K
2.0%
−2.2%
Reduced · −3K sh
5Corcept Therapeutics Inc
COM
$8.0M91.6K
1.8%
New
New position
6Digitalocean Hldgs Inc
COM
$7.9M50.4K
1.7%
−27%
Reduced · −19K sh
7Allegro Microsystems Inc
COM
$7.5M107.9K
1.7%
New
New position
8Mirum Pharmaceuticals Inc
COM
$7.4M63.3K
1.6%
+62%
Added · +24K sh
9Jfrog Ltd
ORD SHS
$7.3M80.7K
1.6%
−32%
Reduced · −39K sh
10Carpenter Technology Corp
COM
$7.2M11.7K
1.6%
−44%
Reduced · −9K sh
11Dycom Inds Inc
COM
$7.2M14.2K
1.6%
−17%
Reduced · −3K sh
12Krystal Biotech Inc
COM
$7.1M19.1K
1.6%
+2.9%
Added · +535 sh
13Commvault Sys Inc
COM
$7.0M49.6K
1.5%
New
New position
14Adaptive Biotechnologies Cor
COM
$7.0M325.2K
1.5%
New
New position
15Zeta Global Holdings Corp
CL A
$6.9M351.4K
1.5%
+133%
Added · +200K sh
16RBC Bearings Inc
COM
$6.8M10.5K
1.5%
−17%
Reduced · −2K sh
17Travere Therapeutics Inc
COM
$6.8M119.0K
1.5%
+147%
Added · +71K sh
18Enova Intl Inc
COM
$6.7M27.7K
1.5%
+7.0%
Added · +2K sh
19Formfactor Inc
COM
$6.6M41.4K
1.5%
+41%
Added · +12K sh
20Ultra Clean Hldgs Inc
COM
$6.6M46.3K
1.5%
−23%
Reduced · −14K sh
21Palvella Therapeutics Inc Ne
COM
$6.6M43.0K
1.4%
+3.7%
Added · +2K sh
22Silicon Motion Technology Co
SPONSORED ADR
$6.5M19.6K
1.4%
−22%
Reduced · −6K sh
23Modine MFG Co
COM
$6.4M24.0K
1.4%
−36%
Reduced · −13K sh
24Crocs Inc
COM
$6.4M52.8K
1.4%
New
New position
25Guardian Pharmacy Svcs Inc
CL A
$6.4M152.0K
1.4%
−19%
Reduced · −36K sh
26Ceco Environmental Corp
COM
$6.1M67.3K
1.3%
+118%
Added · +36K sh
27Extreme Networks Inc
COM
$5.9M183.1K
1.3%
New
New position
28Ligand Pharmaceuticals Inc
COM NEW
$5.9M18.7K
1.3%
−51%
Reduced · −20K sh
29Kiniksa Pharmaceuticals Intl
ORD SHS CL A
$5.6M87.3K
1.2%
+181%
Added · +56K sh
30Heartflow Inc
COM
$5.6M189.7K
1.2%
+53%
Added · +66K sh
31Lattice Semiconductor Corp
COM
$5.6M36.4K
1.2%
−39%
Reduced · −23K sh
32Magnite Inc
COM
$5.5M289.0K
1.2%
−6.6%
Reduced · −20K sh
33Semtech Corp
COM
$5.4M33.6K
1.2%
+9.2%
Added · +3K sh
34Vericel Corp
COM
$5.4M120.4K
1.2%
New
New position
35Lindblad Expeditions Hldgs I
COM
$5.3M186.9K
1.2%
New
New position
36Axsome Therapeutics Inc.
COM
$5.1M20.8K
1.1%
−5.7%
Reduced · −1K sh
37Mercury Sys Inc
COM
$5.1M41.5K
1.1%
−23%
Reduced · −12K sh
38Vse Corp
COM
$5.0M21.8K
1.1%
−25%
Reduced · −7K sh
39Equipmentshare Com Inc
COM CL A
$4.9M248.5K
1.1%
New
New position
40Dave Inc
CLASS A COM NEW
$4.9M13.1K
1.1%
New
New position
41Graham Corp
COM
$4.8M39.0K
1.1%
New
New position
42Onespaworld Holdings Limited
COM
$4.8M170.2K
1.1%
New
New position
43Argan Inc
COM
$4.8M6.0K
1.1%
−42%
Reduced · −4K sh
44Nlight Inc
COM
$4.7M67.1K
1.0%
−31%
Reduced · −30K sh
45Clear Secure Inc
COM CL A
$4.6M81.8K
1.0%
+145%
Added · +48K sh
46Applied Digital Corp
COM NEW
$4.5M121.9K
1.0%
New
New position
47Acadia Healthcare Company In
COM
$4.5M152.4K
1.0%
New
New position
48Remitly Global Inc
COM
$4.3M194.1K
1.0%
New
New position
49Axogen Inc
COM
$4.2M90.6K
0.9%
−11%
Reduced · −12K sh
50Five9 Inc
COM
$4.1M193.7K
0.9%
New
New position
Showing 50 of 109 positions
Build

Ask your agent what Lisanti Capital Growth, LLC owns

This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/funds/1424467/holdings"
Ask your agent
Use Arkolith to show Lisanti Capital Growth, LLC's latest
holdings, largest changes, and filing provenance.

Filing history

As-of date vs the date the SEC received each filing

$454.6M · Q2 2026Q3 2024 · $394.9MQ2 2026 · $454.6M

Reported 13F total per quarter. Raw filing totals can include option notional.

QuarterAs ofFiledLagPositionsValueForm
Q2 2026Jun 30, 2026Aug 10, 202641d109$454.6M13F-HR
Q1 2026Mar 31, 2026May 7, 202637d103$396.8M13F-HR
Q4 2025Dec 31, 2025Feb 9, 202640d110$422.1M13F-HR
Q3 2025Sep 30, 2025Nov 4, 202535d105$408.8M13F-HR
Q2 2025Jun 30, 2025Aug 7, 202538d106$360.8M13F-HR
Q1 2025Mar 31, 2025Apr 25, 202525d108$336.2M13F-HR
Q4 2024Dec 31, 2024Feb 7, 202538d111$415.7M13F-HR
Q3 2024Sep 30, 2024Nov 4, 202435d116$394.9M13F-HR

Data source

Holdings from SEC EDGAR 13F-HR filings, updated quarterly, filed up to 45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. The performance line is a simulation of the disclosed long book, not an audited return.